Lindberg et al., 1990 - Google Patents
Magnesium bioavailability from magnesium citrate and magnesium oxide.Lindberg et al., 1990
- Document ID
- 16134581528915257174
- Author
- Lindberg J
- Zobitz M
- Poindexter J
- Pak C
- Publication year
- Publication venue
- Journal of the American college of nutrition
External Links
Snippet
This study compared magnesium oxide and magnesium citrate with respect to in vitro solubility and in vivo gastrointestinal absorbability. The solubility of 25 mmol magnesium citrate and magnesium oxide was examined in vitro in solutions containing varying amounts …
- 239000011777 magnesium 0 title abstract description 150
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindberg et al. | Magnesium bioavailability from magnesium citrate and magnesium oxide. | |
| Bo-Linn et al. | An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. | |
| Pak | Citrate and renal calculi: new insights and future directions | |
| Pak et al. | Predictive value of kidney stone composition in the detection of metabolic abnormalities | |
| Fine et al. | Intestinal absorption of magnesium from food and supplements. | |
| Pak et al. | Medical therapy and new approaches to management of urolithiasis | |
| Pak | Medical management of nephrolithiasis | |
| Rivers et al. | When and how to evaluate a patient with nephrolithiasis | |
| EP0464299B1 (en) | Antihypertensive preparation | |
| EP0286085A1 (en) | An antacid composition | |
| PAK et al. | Enhanced calcium bioavailability from a solubilized form of calcium citrate | |
| Lam et al. | Rapid gastric emptying in duodenal ulcer patients | |
| Jaeger et al. | Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers | |
| Gregory et al. | Oxalate stone disease after intestinal resection | |
| Goldwasser et al. | Calcium stone disease: an overview | |
| Harvey et al. | Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. | |
| Hawkey et al. | Reduction by enprostil of aspirin-induced blood loss from human gastric mucosa | |
| Sriboonlue et al. | Blood and urinary aggregator and inhibitor composition in controls and renal-stone patients from northeastern Thailand | |
| Morris et al. | Absorption of sulfate from orally administered magnesium sulfate in man | |
| Matzkin et al. | Primary hypomagnesemia with a probable double magnesium transport defect | |
| Cowley et al. | Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria. | |
| Konnak et al. | Renal calculi associated with incomplete distal renal tubular acidosis | |
| Cluysenaer et al. | Malabsorption in coeliac sprue | |
| Ito et al. | Incidence and clinical features of renal tubular acidosis-1 in urolithiasis | |
| Georgitis et al. | An iodine load from water-purification tablets alters thyroid function in humans |